PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis |
| Symptom | |hepatocellular carcinoma |
| Sentences | 261 |
| PubMedID- 23661457 | Evaluation of a histocompatibility antigen related to hepatitis b virus in patients with hepatocellular carcinoma in the western brazilian amazon. |
| PubMedID- 22911171 | Methods: thirty-eight patients who underwent hepatectomy for hepatocellular carcinoma (hcc) with hepatitis c virus infection were included. |
| PubMedID- 25082726 | Although the development of hepatocellular carcinoma following infection with hepatitis virus is a crucial health problem, there are few reports of hemophilia patients undergoing liver resection for hepatocellular carcinoma. |
| PubMedID- 20731020 | hepatocellular carcinoma in patients with chronic hepatitis c virus infection without cirrhosis. |
| PubMedID- 20981260 | A 73-year-old man with a history of hepatocellular carcinoma associated with hepatitis c virus-related cirrhosis was referred to the department of urology because a thickened wall of the urinary bladder was incidentally detected by computed tomography (ct). |
| PubMedID- 24632756 | The serum level of vegf has potential to be a useful predictor of the presence of hepatocellular carcinoma in patients with hepatitis c virus (hcv)-related liver cirrhosis, while serum levels of afp and vegf can predict tumor type and vascular invasion, respectively25. |
| PubMedID- 23509319 | Statins and the risk of hepatocellular carcinoma in patients with hepatitis c virus infection. |
| PubMedID- 25736100 | Suppression of silent information regulator 1 activity in noncancerous tissues of hepatocellular carcinoma: possible association with non-b non-c hepatitis pathogenesis. |
| PubMedID- 23586065 | To evaluate the possible association between the vitamin d receptor (vdr), single-nucleotide polymorphisms (snps), and hepatocellular carcinoma (hcc) in patients with chronic hepatitis b virus (hbv) infection. |
| PubMedID- 23945731 | Random-effects inverse variance meta-analysis of antiviral therapy treatment effects on hepatocellular carcinoma in patients with chronic hepatitis b, subgroups according to trial design. |
| PubMedID- 23547582 | Screening for hepatocellular carcinoma in patients with hepatitis c virus infection. |
| PubMedID- 21665892 | hepatocellular carcinoma: the point of view of the hepatitis b virus. |
| PubMedID- 24662676 | Given the role of hepatocellular cd81 in hcv infection and the association of chronic hepatitis c with hepatocellular carcinoma (hcc) there is a growing interest in studying the function of cd81 in hepatocytes. |
| PubMedID- 24772876 | Concurrent development of non-hodgkin lymphoma and hepatocellular carcinoma in patient with chronic hepatitis c. |
| PubMedID- 25279176 | Time trends of clinical characteristics in hepatocellular carcinoma patients with chronic hepatitis b virus infection: a field survey between 2000 and 2012. |
| PubMedID- 24055508 | Background & aims: hepatocellular carcinoma develops in patients with chronic hepatitis or cirrhosis via a stepwise accumulation of various genetic alterations. |
| PubMedID- 21319193 | Liver stiffness measurement (lsm) using fibroscan accurately assesses the degree of liver fibrosis and the risk of hepatocellular carcinoma (hcc) development in patients with chronic hepatitis c. |
| PubMedID- 23179634 | 2006) and is a susceptibility locus for hepatocellular carcinoma in patients with hepatitis b virus infection (zhang et al. |
| PubMedID- 20495329 | A case of hepatocellular carcinoma with autoimmune hepatitis showing marked reduction of tumors by oral administration of uft-e. |
| PubMedID- 21170112 | Objective: to compare efficacy of plain and contrast enhancement mri (1.5t or 3t) and dynamic contrast enhanced multidetector ct (mdct, 16- or 64 -slice) for the detection of small hepatocellular carcinoma (hcc) in patients with hepatitis b-induced cirrhosis. |
| PubMedID- 24081938 | Statins and reduced risk of hepatocellular carcinoma in patients with hepatitis c virus infection: further evidence is warranted. |
| PubMedID- 24583062 | Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis b treated with entecavir vs lamivudine. |
| PubMedID- 20458764 | Aim: to elucidate the role of insulin resistance (ir) and serum adiponectin level in hepatocellular carcinoma (hcc) associated with chronic hepatitis c. |
| PubMedID- 23689989 | Il28b minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis c virus infection. |
| PubMedID- 25331666 | Increased risk of hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 24843320 | Previous reports have shown that interferon (ifn)-based therapy decreases the risk of development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection. |
| PubMedID- 21766498 | Purpose: the aim of this study was to compare patients with hepatocellular carcinoma (hcc) associated with hepatitis c virus (hcv) infection with patients with liver cirrhosis associated with hcv virus infection. |
| PubMedID- 20594228 | Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis b virus related cirrhosis. |
| PubMedID- 23781497 | Evaluated the possible association between the vitamin d receptor (vdr), single-nucleotide polymorphisms (snps), and hepatocellular carcinoma (hcc) in patients with chronic hepatitis b virus (hbv) infection and found that the c > t polymorphisms at foki position in the vdr gene served as a potential biomarker for the risk and the disease severity of hcc in those infected with hbv. |
| PubMedID- 23258096 | Effect of response to interferon-alpha therapy on the occurrence of hepatocellular carcinoma in patients with chronic hepatitis b. |
| PubMedID- 21133598 | Comparison of serum survivin and alpha fetoprotein in egyptian patients with hepatocellular carcinoma associated with hepatitis c viral infection. |
| PubMedID- 21573177 | Upon hcv infection, up to 80% individuals will develop persistent viraemia and chronic hepatitis, which potentially leads to liver cirrhosis, hepatocellular carcinoma, end-stage liver disease, and liver failure 2. |
| PubMedID- 24576055 | Background & aims: the aim of this study was to re-evaluate the diagnostic performance of alpha-foetoprotein (afp) as a surveillance test for hepatocellular carcinoma (hcc) in patients with hepatitis b virus-related chronic liver disease who were treated with entecavir (etv). |
| PubMedID- 24148650 | Outcomes following liver resection and clinical pathologic characteristics of hepatocellular carcinoma occurring in patients with chronic hepatitis b and minimally fibrotic liver. |
| PubMedID- 24187458 | Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis b. |
| PubMedID- 22695885 | Background: there is limited literature on hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection in the absence of cirrhosis. |
| PubMedID- 24677195 | hepatocellular carcinoma screening in patients with compensated hepatitis c virus (hcv)-related cirrhosis aware of their hcv status improves survival: a modeling approach. |
| PubMedID- 22419005 | Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 22066022 | Serum microrna-21 as marker for necroinflammation in hepatitis c patients with and without hepatocellular carcinoma. |
| PubMedID- 25803433 | Tsan et al used this definition to study statins and the risk of hepatocellular carcinoma in patients with hepatitis b virus infection . |
| PubMedID- 26357607 | Data from the long-term follow-up of patients enrolled in the registration studies showed that treatment with entecavir can lead to significant improvements in liver histopathology, and recent cohort studies have demonstrated that treatment with entecavir may reduce disease progression and the development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis b. |
| PubMedID- 26350363 | Background: hepatocellular carcinoma (hcc) not associated with active hepatitis b virus (hbv) or hepatitis c virus (hcv) infection, termed non-b non-c hcc (nbnc-hcc), is reportedly correlated with better survival outcomes than hbv- or hcv-related hcc. |
| PubMedID- 22555181 | A critical evaluation of the preventive effect of antiviral therapy on the development of hepatocellular carcinoma in patients with chronic hepatitis c or b: a novel approach by using meta-regression. |
| PubMedID- 22819910 | Background/aims: we investigated the clinicopathological findings and outcome after surgery for hepatocellular carcinoma in patients without hepatitis b or c virus infection. |
| PubMedID- 23657093 | Untreated chronic hepatitis c can lead to cirrhosis, hepatocellular carcinoma and death 2. |
| PubMedID- 22899800 | A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis c after sustained response to pegylated interferon and ribavirin combination therapy. |
| PubMedID- 23615731 | A tissue microarray containing hepatocellular carcinoma samples with hepatitis b-positive patients (50 cases, 2 cores per case) and two non-neoplastic liver samples (2 cores per sample) was purchased from accumax (a217). |
| PubMedID- 21619694 | Similar findings have been reported in previous studies, including hepatocellular carcinoma associated with chronic hepatitis c, gastric carcinoma, and sporadic endometrial carcinoma , suggesting an interaction of mdm2 snp309, infectious factor, and hormone factor. |
| PubMedID- 22372460 | hepatocellular carcinoma (hcc) in a patient with hepatitis b virus (hbv) infection. |
| PubMedID- 25654412 | Results: there were 109 patients with hepatocellular carcinoma associated with hepatitis c virus that underwent living-donor liver transplant from july 2002 to june 2012. |